Key result
Target dose beta-blocker treatment was infrequently achieved at discharge, and despite early up-titration, only 31.5% of patients reached a final daily dose >50% of target dose.
Observational (n=100)
No
Real-world data shows that target doses of beta-blockers are infrequently achieved at discharge following MI, and most patients remain below target doses at 1 year despite some up-titration.
Answers are grounded in this paper and cite their sources.
Target beta-blocker doses remain underachieved post-MI despite up-titration; leaves open optimal strategies and outcome impact in real-world cohorts.
BACKGROUND: Beta-blocker (BB) therapy after myocardial infarction (MI) reduces all-cause mortality. OBJECTIVE: The aim of this study was to investigate BB dosing patterns and compliance following MI. METHODS: Using medical patient files and nationwide databases, we identified 100 patients who were discharged following MI in 2012 from Aarhus University Hospital, Denmark, and subsequently redeemed one or more BB prescriptions within 6 months. We obtained information about all BB medication prescribed at discharge and all BB prescriptions redeemed until 31 December 2013. Daily BB doses were computed as percentages of the target doses used in clinical trials documenting the efficacy of BBs after MI. Four dose groups were defined: ≤12.5, >12.5-25, >25-50, and >50 % of target dose. The proportion of patients in each dose group was ascertained at and following discharge, as was the proportion that changed dose group following discharge. RESULTS: The median study period was 400 days (interquartile range [IQR] 318-486 days). At discharge, 8 % of daily doses were >50 % of target dose while 80 % were ≤25 % of target dose. At first prescription redemption, 71.7 % of patients moved to a higher dose group (median dose change = 33.4 % [IQR 2.0-115.1]). Still, comparing final daily doses to discharge doses, 40.2 % did not change dose group (median dose change -5.7 % [IQR -18.0 to 4.2]). Only 31.5 % reached a final daily dose >50 % of target dose. CONCLUSIONS: Target dose BB treatment was infrequently achieved at discharge following MI. Despite dose up-titration early after discharge, most patients did not receive target dose BB treatment approximately 1 year following MI.
No takes yet. Share an insight, caveat, or question.
Pedersen et al. (2016) conducted an observational in Myocardial Infarction (n=100). Beta-blocker therapy vs. Discharge dose vs subsequent pharmacy-dispensed dose was evaluated on Proportion of patients achieving >50% of target beta-blocker dose. Target dose beta-blocker treatment was infrequently achieved at discharge, and despite early up-titration, only 31.5% of patients reached a final daily dose >50% of target dose.
Synapse has enriched 10 related papers. Consider them for comparative context: